| MBP - Myelin Basic Protein | |
|---|---|
| Symbol | MBP |
| Full Name | Myelin Basic Protein |
| Chromosome | 18q23 |
| NCBI Gene ID | [4155](https://www.ncbi.nlm.nih.gov/gene/4155) |
| OMIM | [159430](https://www.omim.org/entry/159430) |
| Ensembl | [ENSG00000197971](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000197971) |
| UniProt | [P02686](https://www.uniprot.org/uniprot/P02686) |
| Associated Diseases | [Multiple Sclerosis](/diseases/multiple-sclerosis), [Alzheimer's Disease](/diseases/alzheimers-disease), Demyelinating Disorders |
MBP (Myelin Basic Protein) is a major protein component of the myelin sheath in the central nervous system (CNS), constituting approximately 30% of total myelin protein [1]. MBP is essential for the structural integrity and functional maintenance of myelin, the lipid-rich multilayered membrane that surrounds axons and enables rapid saltatory conduction of nerve impulses.
The MBP gene encodes a family of isoforms generated by alternative splicing, with the major isoforms being 18.5 kDa, 17.2 kDa, and 21.5 kDa proteins [2]. These isoforms are expressed in a developmentally regulated manner, with different isoforms predominant at different stages of oligodendrocyte maturation and myelination.
MBP has garnered significant attention in neurodegenerative research due to its central role in demyelinating diseases, particularly multiple sclerosis (MS), where autoimmunity against MBP is a hallmark of disease pathogenesis [3]. Additionally, myelin abnormalities have been documented in Alzheimer's disease and other neurodegenerative conditions.
The MBP gene spans approximately 32 kb on chromosome 18q23 and consists of 11 exons. The gene generates multiple mRNA isoforms through alternative splicing of the primary transcript [4]:
| Isoform | Size (kDa) | Expression Pattern |
|---|---|---|
| MBP-C | 21.5 | Early development, early myelination |
| MBP-A | 18.5 | Adult brain, predominant isoform |
| MBP-B | 17.2 | Adult brain, alternative splicing |
| MBP-tr | 14.0 | Minor isoform |
The structural differences between isoforms confer distinct functional properties, including variations in subcellular localization and interaction with other myelin proteins. The 18.5 kDa isoform is the most abundant in adult human brain and is the primary antigen in MBP-specific T-cell responses [5].
MBP plays a critical structural role in the myelin sheath:
Beyond its structural role, MBP participates in signaling processes:
| Partner | Interaction | Function |
|---|---|---|
| PLP | Structural | Myelin stability |
| MOG | Immune | Autoantigen |
| Actin | Cytoskeletal | Membrane organization |
| CaM | Calcium signaling | Second messenger |
MBP expression is highly specific to the nervous system:
In the brain, MBP is expressed throughout:
The regional distribution correlates with the degree of myelination, with highest levels in areas with dense white matter tracts [7].
MBP is central to multiple sclerosis pathogenesis through multiple mechanisms [8]:
The clinical progression of MS correlates with the balance between demyelination and remyelination, with MBP serving as both a marker of myelin integrity and a therapeutic target.
Emerging evidence links MBP to Alzheimer's disease [11]:
MBP is relevant to several other conditions:
Targeting MBP offers therapeutic potential for demyelinating diseases:
| Approach | Strategy | Status |
|---|---|---|
| T-cell modulation | Altered peptide ligands | Clinical trials |
| B-cell depletion | Anti-CD20 antibodies | Approved for MS |
| Remyelination | Cleavage proteins | Preclinical |
| MBP replacement | Gene therapy | Investigational |
The challenge in targeting MBP lies in balancing immunosuppressive effects with the need to preserve protective immune responses [12]. Furthermore, promoting remyelination remains challenging due to the limited regenerative capacity of oligodendrocyte precursor cells in chronic lesions [13].
Key questions about MBP in neurodegeneration include: